Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors

Creative Commons License

KUTLU M., ERGİN Ç., Sen-Turk N., SAYIN KUTLU S., ZORBOZAN O., AKALIN Ş., ...More

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.9, no.2, pp.141-148, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 9 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.3855/jidc.5155
  • Journal Name: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.141-148
  • Keywords: experimental brucellosis, anti-TNF-alpha drug, etanercept, infliximab, ANTI-TNF-ALPHA, RHEUMATOID-ARTHRITIS, MOUSE MODEL, INFLIXIMAB, ABORTUS, PATIENT, EXPRESSION, HEPATITIS, DISEASE, TOLL-LIKE-RECEPTOR-4
  • Akdeniz University Affiliated: Yes

Abstract

Introduction: There is limited data in the literature about brucellosis related to an intracellular pathogen and anti-tumor necrosis factor alpha (anti-TNF alpha) medication. The aim of this study was to evaluate acute Brucella infections in mice receiving anti-TNF alpha drug treatment.